Alliance Pharma PLC received a notification of major holdings from Slater Investments on July 22, 2024. The notification indicates that Slater Investments now holds 13.08% of the voting rights in Alliance Pharma PLC, representing a 1.08% increase from the previous notification. This increase is attributed to the acquisition of direct and indirect voting rights, with 2.65% and 10.43% respectively. The total number of voting rights held by Slater Investments in Alliance Pharma PLC is 70,675,966.

The notification also includes details of the person subject to the notification obligation, with Mark Slater being the ultimate controlling person of Slater Investments. The notification does not provide information regarding proxy voting or additional details.

This notification, submitted in the standard form for notification of major holdings, provides transparency about the changes in voting rights within Alliance Pharma PLC and the involvement of Slater Investments.